The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

What strategies can pharma employ to protect itself against cyber threats?

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

Looking to pivot your business model to a CDMO service offering? Here’s what to keep in mind.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

How can we maximize the potential and production of potentially life-saving therapies?

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Sitting Down With… Andrew Moore, General Manager of Pfizer CentreOne.

Sandoz’s Pierre Bourdage talks to us about biosimilars and how uptake can be boosted.